- Home
- GPCR vs LION Comparison
GPCR vs LION Comparison
Compare GPCR & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- LION
- Stock Information
- Founded
- GPCR 2016
- LION 1997
- Country
- GPCR United States
- LION Canada
- Employees
- GPCR N/A
- LION N/A
- Industry
- GPCR
- LION Movies/Entertainment
- Sector
- GPCR
- LION Consumer Discretionary
- Exchange
- GPCR Nasdaq
- LION Nasdaq
- Market Cap
- GPCR 1.8B
- LION 2.0B
- IPO Year
- GPCR 2023
- LION N/A
- Fundamental
- Price
- GPCR $40.36
- LION $7.10
- Analyst Decision
- GPCR Buy
- LION Strong Buy
- Analyst Count
- GPCR 6
- LION 3
- Target Price
- GPCR $81.33
- LION $11.83
- AVG Volume (30 Days)
- GPCR 593.8K
- LION 121.2K
- Earning Date
- GPCR 08-08-2024
- LION 08-08-2024
- Dividend Yield
- GPCR N/A
- LION N/A
- EPS Growth
- GPCR N/A
- LION N/A
- EPS
- GPCR N/A
- LION N/A
- Revenue
- GPCR N/A
- LION $2,949,800,000.00
- Revenue This Year
- GPCR N/A
- LION $11.34
- Revenue Next Year
- GPCR N/A
- LION $7.19
- P/E Ratio
- GPCR N/A
- LION N/A
- Revenue Growth
- GPCR N/A
- LION N/A
- 52 Week Low
- GPCR $26.61
- LION $6.13
- 52 Week High
- GPCR $75.02
- LION $12.84
- Technical
- Relative Strength Index (RSI)
- GPCR 57.92
- LION 48.44
- Support Level
- GPCR $38.27
- LION $6.57
- Resistance Level
- GPCR $42.67
- LION $7.31
- Average True Range (ATR)
- GPCR 2.29
- LION 0.45
- MACD
- GPCR 0.31
- LION 0.04
- Stochastic Oscillator
- GPCR 76.72
- LION 51.79
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About LION Lionsgate Studios Corp. Common Shares
Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.